Toronto Stock Exchange (TSX) · TRIL.TO · ISIN CA89624T1057
Trillium Therapeutics Inc.
No trading activity has been reported for this listing since April 24, 2025. It may be delisted, halted or inactive.
23.33 CAD
April 24, 2025
Trillium Therapeutics Inc. (TRIL.TO) trades on the Toronto Stock Exchange and operates in the Biotechnology industry. The company reports around 33 employees. Its ISIN is CA89624T1057. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.
Key facts
Exchange
Toronto Stock Exchange (TSX)
ISIN
CA89624T1057
Sector
Healthcare
Industry
Biotechnology
Country
CA
Employees
33
Previous close
23.33 CAD
Day range
23.22 – 23.45
52-week range
7.48 – 24.62
Volume
60.42K
50-day average
22.18 CAD
200-day average
14.96 CAD
Asset type
Equity
About Trillium Therapeutics Inc.
Trillium Therapeutics Inc. is a clinical-stage biotechnology firm specializing in immuno-oncology, dedicated to discovering and developing innovative cancer treatments. Its leading experimental therapy, TTI-621, is a SIRPaFc fusion protein engineered to function as a soluble decoy receptor, effectively blocking the inhibitory signaling pathway of CD47. This compound is currently undergoing Phase I clinical evaluations for patients suffering from advanced, recurrent, or treatment-resistant hematological cancers, as well as solid tumors and mycosis fungoides. The company's drug development pipeline also features TTI-622, an immunoglobulin G4 SIRPaFc protein that is likewise in Phase I clinical trials. Additionally, Trillium is in the discovery stage for TTI-10001, a small molecule agonist designed to stimulate interferon genes by detecting cytosolic DNA, thereby enhancing anti-tumor immunity. Founded in 2004, the company, headquartered in Mississauga, Canada, operated under the name Stem Cell Therapeutics Corp. before officially changing to Trillium Therapeutics Inc. in June 2014.
Company websiteFrequently asked
- What is the TRIL.TO share price today?
- This page shows the latest available Trillium Therapeutics Inc. (TRIL.TO) price with its change against the prior close. Values are delayed or previous-close, not real-time.
- Where is Trillium Therapeutics Inc. listed?
- Trillium Therapeutics Inc. trades on the Toronto Stock Exchange under the symbol TRIL.TO, ISIN CA89624T1057.
+
+
All Trillium Therapeutics Inc. data comes from exchange and provider feeds for the Toronto Stock Exchange and is published for information, not as investment advice.
Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.